Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

World Health Organization

Can Cinderella save us?

Roche buys GeneWeave to boost antibiotics portfolio

Swiss firm buys into a new diagnostic technology called ‘Smarticles’

- PMLiVE

Sharing knowledge to combat emerging threats

'One health' advocates say closer cooperation between human and animal medicine firms could offer new solution

Can Cinderella save us?

Pharma should pay into antibiotic resistance fund

Claims stem from the latest UK Review on Antimicrobial Resistance

Can Cinderella save us?

UK government warns over antibiotic resistant deaths

Cabinet Office document says the next 20 years is a crucial period for creating new medicines

Curbing the rise of drug resistance

The pharma sector could hold the greatest power to address the global threat of antimicrobial resistance

- PMLiVE

Call for closer ties between pharma and animal health

One Health conference hears how joint workingcould benefit both sectors

Cubist’s Dr Lorianne Masuoka jumps ship to InVivo

Comes amidst MSD’s recent takeover of the antibiotic specialist

EU flag

Antibiotics among 7 new drugs backed by EMA

The Medicines Company’s Orbactiv and Cubist’s Sivextro set for European approval

- PMLiVE

FDA backs Cubist’s antibiotic Zerbaxa

Combination cephalosporin and beta lactamase inhibitor wins US approval

The impending threat of antibiotic resistance

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

Xellia forms scientific advisory board

Will further progress on innovative anti-infectives

Can Cinderella save us?

Antibiotic resistance to lead to millions of deaths

UK publishes first progress report for antimicrobial resistance strategy

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links